Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Sarepta Therapeutics Inc (SRPT)

339 + Investors. Track Smart Money conviction in SRPT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -7
Streak
1Q ▼
Buyers last Q
46%

Smart Money Signals — SRPT

Based on 342 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their SRPT positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 71% of 3.0Y peak

71% of all-time peak
342 funds currently hold this stock — 71% of the 3.0-year high of 483 funds (reached 2024 Q2). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📉

Outflows — 21% fewer funds vs a year ago

fund count last 6Q
89 fewer hedge funds hold SRPT compared to a year ago (-21% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟠

More sellers than buyers — 46% buying

164 buying192 selling
Last quarter: 192 funds reduced or exited vs 164 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
⚠️

Fewer new buyers each quarter (-30 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 66 → 60 → 77 → 47. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

62% of holders stayed for 2+ years

■ 62% conviction (2yr+) ■ 18% medium ■ 20% new
212 out of 342 hedge funds have held SRPT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +241% but shares only +10% — price-driven

Value
+241%
Shares
+10%
Last quarter: the total dollar value of institutional holdings rose +241%, but actual share count only changed +10%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
➡️

Steady discovery — ~47 new funds/quarter

72 → 66 → 60 → 77 → 47 new funds/Q
New funds entering each quarter: 66 → 60 → 77 → 47. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 69% veterans vs 21% newcomers

■ 69% veterans ■ 10% 1-2yr ■ 21% new
Entry-cohort mix of 367 holders: 255 (69%) are 2+ year veterans, 35 entered 1–2 years ago, and 77 (21%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 82% AUM from top-100 funds

82% from top-100 AUM funds
51 of 339 holders are among the 100 largest funds by AUM, controlling 82% of total institutional value in SRPT. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
2.2
out of 10
Low Exit Risk
Exit risk score 2.2/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — SRPT

In 2026 Q1, 164 hedge funds were net buyers of SRPT (47 opened a new position, 117 added to an existing one), while 192 reduced or exited (138 trimmed, 54 sold completely) — a 46% buyer ratio, indicating roughly balanced activity. 82% of total institutional value in SRPT is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -7 funds (more exits than new entries). Total institutional holders: 342.

Hedge Fund Ownership: SRPT

How many hedge funds hold SRPT — quarterly history vs. share price
Quarterly hedge fund ownership of SRPT vs. share price

Market Analysis: SRPT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: SRPT

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Sarepta Therapeutics Inc (SRPT) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much SRPT has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 81d ago
SRPT
-19.4%
XLV
+2.1%

SRPT outperformed XLV by -21.5% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 36d ago
SRPT
-0.1%
XLV
+3.2%

Since the filing became public, SRPT outperformed XLV by -3.3% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

27 top-rated funds 1 high-conviction
Consensus
6.3
/ 10
breadth
×
Elite
1.7
/ 10
conviction
Hedge Fund Positioning: SRPT
339 + Investors

Track Smart Money conviction in SRPT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 339 349 -2.87%
13F Shares 112M 101M 10.27%
Total Value $7.47B $2.19B 240.99%
New Positions 45 77 -32
Increased Positions 110 132 -22
Closed Positions 55 44 +11
Reduced Positions 130 97 +33
Total Calls 13 22 -40.91%
Total Puts 15 19 -21.05%
PUT/CALL Ratio 1.15 0.86 Neutral

Statistics: SRPT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

339 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in SRPT. Verified SEC 13F-HR filings.

QUARTER:
Top 25 SRPT holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Lion Point Capital, LP 3.71% 28,500 $620K
2 Ra Capital Management, L.P. 0.90% 3,902,596 $84.9M
3 683 Capital Management, LLC 0.85% 750,000 $16.3M
4 Scientech Research LLC 0.60% 33,008 $718K
5 Erste Asset Management GmbH 0.57% 2,968,945 $61.3M
6 Boxer Capital Management, LLC 0.43% 150,000 $3.3M
7 Voleon Capital Management LP 0.38% 800,660 $17.4M
8 ADAR1 Capital Management, LLC 0.34% 262,058 $5.7M
9 Axq Capital, LP 0.28% 98,212 $2.1M
10 Virtus Advisers, LLC 0.26% 25,800 $561K
11 Virtus Investment Advisers, LLC 0.24% 39,213 $853K
12 Privium Fund Management B.V. 0.21% 46,000 $1.0M
13 Generali Investments CEE, investicni spolecnost, a.s. 0.19% 163,290 $3.6M
14 Bayforest Capital Ltd 0.17% 7,121 $155K
15 Highbridge Capital Management LLC 0.17% 250,000 $5.1M
16 Jump Financial, LLC 0.15% 507,828 $11.1M
17 Nebula Research & Development LLC 0.14% 98,075 $1.7M
18 Atlantic Private Wealth, LLC 0.11% 7,500 $163K
19 Bull Harbor Capital LLC 0.11% 18,298 $398K
20 Caerus Investment Advisors, LLC 0.09% 9,854 $214K
21 Two Sigma Advisers, LP 0.09% 2,071,334 $44.6M
22 Aberdeen Group plc 0.08% 2,318,890 $50.5M
23 Two Sigma Investments, LP 0.08% 4,593,195 $99.9M
24 Catalyst Funds Management Pty Ltd 0.07% 19,200 $418K
25 Landscape Capital Management, L.L.C. 0.07% 50,298 $1.1M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Sarepta Therapeutics Inc (SRPT)

What does the Smart Money Trend signal show for SRPT?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their SRPT positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for SRPT?

More sellers than buyers — 46% buying: Last quarter: 192 funds reduced or exited vs 164 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for SRPT holders?

Elite ownership — 82% AUM from top-100 funds: 51 of 339 holders are among the 100 largest funds by AUM, controlling 82% of total institutional value in SRPT. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held SRPT?

62% of holders stayed for 2+ years: 212 out of 342 hedge funds have held SRPT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Sarepta Therapeutics Inc (SRPT) following the 2026 Q1 hedge fund 13F filings?

As of today, SRPT has moved -0.1% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of -3.3%. Since the quarter end (March 31, 2026), SRPT has gained -19.4% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →